SQI Diagnostics Performance
| SQIDFDelisted Stock | USD 0.01 0.00 0.00% |
The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and SQI Diagnostics are completely uncorrelated.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days SQI Diagnostics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental indicators, SQI Diagnostics is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 2.3 M |
SQI |
SQI Diagnostics Relative Risk vs. Return Landscape
If you would invest 1.49 in SQI Diagnostics on September 12, 2024 and sell it today you would earn a total of 0.00 from holding SQI Diagnostics or generate 0.0% return on investment over 90 days. SQI Diagnostics is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded pink sheets are less volatile than SQI, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
SQI Diagnostics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for SQI Diagnostics' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as SQI Diagnostics, and traders can use it to determine the average amount a SQI Diagnostics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| SQIDF |
Based on monthly moving average SQI Diagnostics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of SQI Diagnostics by adding SQI Diagnostics to a well-diversified portfolio.
SQI Diagnostics Fundamentals Growth
SQI Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of SQI Diagnostics, and SQI Diagnostics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on SQI Pink Sheet performance.
| Return On Equity | -12.54 | |||
| Return On Asset | -0.94 | |||
| Profit Margin | (2.29) % | |||
| Operating Margin | (1.71) % | |||
| Current Valuation | 34.24 M | |||
| Shares Outstanding | 406.25 M | |||
| Price To Earning | (2.35) X | |||
| Price To Book | 16.12 X | |||
| Price To Sales | 3.91 X | |||
| Revenue | 8.1 M | |||
| EBITDA | (12.12 M) | |||
| Cash And Equivalents | 3.96 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 6.3 M | |||
| Debt To Equity | 4.64 % | |||
| Book Value Per Share | (0.03) X | |||
| Cash Flow From Operations | (9.82 M) | |||
| Earnings Per Share | (0.02) X | |||
| Total Asset | 9.31 M | |||
| Retained Earnings | (55.6 M) | |||
| Current Asset | 1.67 M | |||
| Current Liabilities | 584 K | |||
About SQI Diagnostics Performance
By analyzing SQI Diagnostics' fundamental ratios, stakeholders can gain valuable insights into SQI Diagnostics' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if SQI Diagnostics has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if SQI Diagnostics has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
SQI Diagnostics Inc., a precision medicine company, discovers, develops, and commercializes rapid diagnostic testing services for healthcare providers, patients, and consumers worldwide. SQI Diagnostics Inc. was founded in 1999 and is headquartered in Toronto, Canada. Sqi Diagnostics is traded on OTC Exchange in the United States.Things to note about SQI Diagnostics performance evaluation
Checking the ongoing alerts about SQI Diagnostics for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for SQI Diagnostics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| SQI Diagnostics is not yet fully synchronised with the market data | |
| SQI Diagnostics has some characteristics of a very speculative penny stock | |
| SQI Diagnostics has a very high chance of going through financial distress in the upcoming years | |
| SQI Diagnostics has accumulated 6.3 M in total debt with debt to equity ratio (D/E) of 4.64, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. SQI Diagnostics has a current ratio of 0.58, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist SQI Diagnostics until it has trouble settling it off, either with new capital or with free cash flow. So, SQI Diagnostics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like SQI Diagnostics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for SQI to invest in growth at high rates of return. When we think about SQI Diagnostics' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 8.1 M. Net Loss for the year was (18.52 M) with profit before overhead, payroll, taxes, and interest of 3.1 M. | |
| SQI Diagnostics has accumulated about 3.96 M in cash with (9.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. | |
| Roughly 51.0% of SQI Diagnostics outstanding shares are owned by corporate insiders |
- Analyzing SQI Diagnostics' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether SQI Diagnostics' stock is overvalued or undervalued compared to its peers.
- Examining SQI Diagnostics' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating SQI Diagnostics' management team can have a significant impact on its success or failure. Reviewing the track record and experience of SQI Diagnostics' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of SQI Diagnostics' pink sheet. These opinions can provide insight into SQI Diagnostics' potential for growth and whether the stock is currently undervalued or overvalued.
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in SQI Pink Sheet
If you are still planning to invest in SQI Diagnostics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the SQI Diagnostics' history and understand the potential risks before investing.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Transaction History View history of all your transactions and understand their impact on performance |